BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

2353

543264

NURECA

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

NURECA LIMITED performance

Today’s low

Today’s high

₹ 231.01 ₹ 235.00
₹ 231.01

52 week low

52 week high

₹ 203.62 ₹ 447.50
₹ 231.01

Open Price

₹ 231.01

Prev. Close

₹ 235.00

Volume (Shares)

528.00

Total traded value

₹ 1.21

Upper Circuit

₹ 239.70

Lower Circuit

₹ 230.30

info

NURECA LIMITED Share Price Update

As of the latest trading session, NURECA LIMITED share price is currently at ₹ 231.01, which is down by ₹ -3.99 from its previous closing. Today, the stock has fluctuated between ₹ 231.01 and ₹ 235.00. Over the past year, NURECA LIMITED has achieved a return of -19.95 %. In the last month alone, the return has been 5.51 %. Read More...

NURECA LIMITED fundamentals


  • Market cap (Cr)

    231.01

  • P/E Ratio (TTM)

    -32.65

  • Beta

    0.68

  • Book Value / share

    193.42

  • Return on equity

    -1.12%

  • EPS (TTM)

    0.00

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    -3.29

info icon alternate text
  • Market cap (Cr)

    233.45

  • P/E Ratio (TTM)

    -32.65

  • Beta

    0.54

  • Book Value / share

    193.42

  • Return on equity

    -1.12%

  • EPS (TTM)

    0.00

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    -3.29

info icon alternate text

NURECA LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 27.21
Operating Expense 32.57
Net Profit -3.29
Net Profit Margin (%) -12.09
Earnings Per Share (EPS) -3.29
EBITDA -3.21
Effective Tax Rate (%) 14.54
Particulars SEP 2024 (Values in Cr)
Revenue 32.37
Operating Expense 35.85
Net Profit -0.65
Net Profit Margin (%) -2.00
Earnings Per Share (EPS) -0.65
EBITDA 0.54
Effective Tax Rate (%) -140.74
Particulars JUN 2024 (Values in Cr)
Revenue 23.31
Operating Expense 26.97
Net Profit 1.20
Net Profit Margin (%) 5.14
Earnings Per Share (EPS) 1.19
EBITDA 2.90
Effective Tax Rate (%) 44.90
Particulars MAR 2024 (Values in Cr)
Revenue 19.56
Operating Expense 25.06
Net Profit -4.41
Net Profit Margin (%) -22.54
Earnings Per Share (EPS) -4.41
EBITDA -6.01
Effective Tax Rate (%) 34.56
Particulars DEC 2023 (Values in Cr)
Revenue 22.37
Operating Expense 27.46
Net Profit 0.08
Net Profit Margin (%) 0.35
Earnings Per Share (EPS) 0.08
EBITDA 1.49
Effective Tax Rate (%) 90.36
Particulars MAR 2024 (Values in Cr)
Revenue 94.52
Operating Expense 108.35
Net Profit -2.44
Net Profit Margin (%) -2.58
Earnings Per Share (EPS) -2.44
EBITDA -0.56
Effective Tax Rate (%) 25.38
Particulars MAR 2023 (Values in Cr)
Revenue 111.90
Operating Expense 130.02
Net Profit -8.42
Net Profit Margin (%) -7.52
Earnings Per Share (EPS) -8.40
EBITDA -8.23
Effective Tax Rate (%) 23.17
Particulars MAR 2022 (Values in Cr)
Revenue 255.55
Operating Expense 201.94
Net Profit 45.31
Net Profit Margin (%) 17.73
Earnings Per Share (EPS) 45.31
EBITDA 63.48
Effective Tax Rate (%) 26.12
Particulars MAR 2021 (Values in Cr)
Revenue 213.33
Operating Expense 153.66
Net Profit 46.53
Net Profit Margin (%) 21.81
Earnings Per Share (EPS) 62.25
EBITDA 64.50
Effective Tax Rate (%) 25.54
Particulars MAR 2020 (Values in Cr)
Revenue 99.43
Operating Expense 90.86
Net Profit 6.41
Net Profit Margin (%) 6.44
Earnings Per Share (EPS) 6405.00
EBITDA 9.75
Effective Tax Rate (%) 25.63
Particulars MAR 2024 (Values in Cr)
Book Value / Share 193.11
ROE % -3.14
ROCE % -4.00
Total Debt to Total Equity 0.02
EBITDA Margin -6.05
Particulars MAR 2023 (Values in Cr)
Book Value / Share 194.88
ROE % -5.37
ROCE % -6.26
Total Debt to Total Equity 0.02
EBITDA Margin -9.29
Particulars MAR 2022 (Values in Cr)
Book Value / Share 203.20
ROE % 24.55
ROCE % 32.88
Total Debt to Total Equity 0.02
EBITDA Margin 24.73
Particulars MAR 2021 (Values in Cr)
Book Value / Share 163.10
ROE % 52.09
ROCE % 66.51
Total Debt to Total Equity 0.08
EBITDA Margin 30.15
Particulars MAR 2020 (Values in Cr)
Book Value / Share 14934.00
ROE % 58.47
ROCE % 58.21
Total Debt to Total Equity 0.47
EBITDA Margin 9.81
Particulars MAR 2024 (Values in Cr)
Book Value / Share 192.86
ROE % -1.12
ROCE % -1.18
Total Debt to Total Equity 0.01
EBITDA Margin -0.11
Particulars MAR 2023 (Values in Cr)
Book Value / Share 195.26
ROE % -4.22
ROCE % -5.16
Total Debt to Total Equity 0.02
EBITDA Margin -7.35
Particulars MAR 2022 (Values in Cr)
Book Value / Share 203.74
ROE % 24.69
ROCE % 33.01
Total Debt to Total Equity 0.02
EBITDA Margin 24.84
Particulars MAR 2021 (Values in Cr)
Book Value / Share 163.29
ROE % 52.20
ROCE % 66.65
Total Debt to Total Equity 0.08
EBITDA Margin 30.23
Particulars MAR 2020 (Values in Cr)
Book Value / Share 14970.00
ROE % 85.35
ROCE % 75.63
Total Debt to Total Equity 0.65
EBITDA Margin 9.83
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 45.30
Total Assets 205.16
Total Liabilities 205.16
Total Equity 193.11
Share Outstanding 10000175
Price to Book Ratio 1.32
Return on Assets (%) -0.87
Return on Capital (%) -0.93
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 70.96
Total Assets 206.58
Total Liabilities 206.58
Total Equity 194.88
Share Outstanding 10000175
Price to Book Ratio 1.54
Return on Assets (%) -3.99
Return on Capital (%) -4.23
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 84.35
Total Assets 219.13
Total Liabilities 219.13
Total Equity 203.19
Share Outstanding 10000175
Price to Book Ratio 6.69
Return on Assets (%) 20.51
Return on Capital (%) 22.12
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 126.69
Total Assets 185.75
Total Liabilities 185.75
Total Equity 163.09
Share Outstanding 10000175
Price to Book Ratio 3.69
Return on Assets (%) 24.96
Return on Capital (%) 28.26
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.07
Total Assets 33.88
Total Liabilities 33.88
Total Equity 14.93
Share Outstanding 10000
Price to Book Ratio 0.00
Return on Assets (%) 18.87
Return on Capital (%) 26.26
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 45.20
Total Assets 204.33
Total Liabilities 204.33
Total Equity 192.85
Share Outstanding 10000175
Price to Book Ratio 1.32
Return on Assets (%) -1.19
Return on Capital (%) -1.26
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 70.86
Total Assets 206.68
Total Liabilities 206.68
Total Equity 195.26
Share Outstanding 10000175
Price to Book Ratio 1.54
Return on Assets (%) -4.07
Return on Capital (%) -4.31
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 84.18
Total Assets 219.53
Total Liabilities 219.53
Total Equity 203.74
Share Outstanding 10000175
Price to Book Ratio 6.69
Return on Assets (%) 20.63
Return on Capital (%) 22.24
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 126.44
Total Assets 185.88
Total Liabilities 185.88
Total Equity 163.29
Share Outstanding 10000175
Price to Book Ratio 3.69
Return on Assets (%) 25.03
Return on Capital (%) 28.34
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 33.86
Total Liabilities 33.86
Total Equity 14.97
Share Outstanding 10000
Price to Book Ratio 0.00
Return on Assets (%) 18.93
Return on Capital (%) 26.36
Particulars MAR 2024 (Values in Cr)
Net Income -2.54
Cash from Operations -3.96
Cash from Investing 17.57
Cash from Financing -1.30
Net change in Cash 13.56
Free Cash Flow -2.87
Particulars MAR 2023 (Values in Cr)
Net Income -10.74
Cash from Operations 14.37
Cash from Investing -16.45
Cash from Financing -1.50
Net change in Cash -7.73
Free Cash Flow 14.77
Particulars MAR 2022 (Values in Cr)
Net Income 60.98
Cash from Operations 19.35
Cash from Investing -3.08
Cash from Financing -7.30
Net change in Cash -8.99
Free Cash Flow 22.75
Particulars MAR 2021 (Values in Cr)
Net Income 62.33
Cash from Operations 49.93
Cash from Investing -110.04
Cash from Financing 92.34
Net change in Cash 17.16
Free Cash Flow 50.35
Particulars MAR 2020 (Values in Cr)
Net Income 8.60
Cash from Operations -7.91
Cash from Investing -0.39
Cash from Financing 8.27
Net change in Cash -0.04
Free Cash Flow -7.50
Particulars MAR 2024 (Values in Cr)
Net Income -3.26
Cash from Operations -4.48
Cash from Investing 17.83
Cash from Financing -1.27
Net change in Cash 13.56
Free Cash Flow -3.98
Particulars MAR 2023 (Values in Cr)
Net Income -10.95
Cash from Operations 16.18
Cash from Investing -18.30
Cash from Financing -1.50
Net change in Cash -7.75
Free Cash Flow 16.42
Particulars MAR 2022 (Values in Cr)
Net Income 61.33
Cash from Operations 19.78
Cash from Investing -3.36
Cash from Financing -7.30
Net change in Cash -8.84
Free Cash Flow 23.04
Particulars MAR 2021 (Values in Cr)
Net Income 62.49
Cash from Operations 50.16
Cash from Investing -110.48
Cash from Financing 92.33
Net change in Cash 16.96
Free Cash Flow 50.26
Particulars MAR 2020 (Values in Cr)
Net Income 8.62
Cash from Operations -7.84
Cash from Investing -0.39
Cash from Financing 8.20
Net change in Cash -0.04
Free Cash Flow -7.43
Company Name Price P/E P/B Market Cap 52 Week Low/High
MSTC LIMITED 511.80 20.37 3.70 3603.07 410.80 / 1037.00
NIHAR INFO GLOBAL LTD. 5.35 0.00 0.59 5.57 4.01 / 7.47
INFO EDGE (I) LTD 7048.45 139.96 2.18 91336.72 5260.00 / 9194.95
INTRASOFT TECH. LTD 101.58 13.06 0.75 165.69 90.00 / 191.40
Company Name Price P/E P/B Market Cap 52 Week Low/High
MSTC LIMITED 511.80 23.87 5.04 3603.07 410.80 / 1037.00
Mitshi India Limited 15.99 0.00 5.22 14.07 13.01 / 36.88
AVI PRODUCTS INDIA LIMITED 23.50 65.28 1.09 7.77 18.25 / 29.29
OLYMPIA INDUSTRIES LTD. 40.75 22.27 0.58 24.55 36.00 / 74.66

NURECA LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
231.01 -1.69 redarrow
red-green-graph indicator
14 Bearish
2 Bullish
  • 5 Days 236.90
  • 26 Days 235.20
  • 10 Days 237.20
  • 50 Days 244.10
  • 12 Days 236.60
  • 100 Days 261.70
  • 20 Days 234.80
  • 200 Days 279.40
235.87 PIVOT

First Support

234.13

First Resistance

236.74

Second Support

233.26

Second Resistance

238.48

Third Support

231.52

Third Resistance

239.35

RSI

46.83

ADX

17.85

MACD

1.33

Williams % R

-54.58

Commodity Channel Index (CCI)

12.30

Date

2025-04-09

Week

5436.00

Same Day

4058.00

Month

14118.00

1 Year

0.68

3 Year

0.84

Over 1 Month

5.51%

down

Over 1 Year

-19.95%

down

Over 3 Months

-19.89%

down

Over 3 Years

-43.54%

down

Over 6 Months

-21.67%

down

Over 5 Years

-18.58%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

NURECA LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
34.58%
Promoter Holdings
64.3%
FII
1.07%
DII
0.03%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Saurabh Goyal 3186158.0 (31.86%) Shareholding of Promoter and Promoter Group
Payal Goyal 2459928.0 (24.6%) Shareholding of Promoter and Promoter Group
Aryan Goyal 723353.0 (7.23%) Shareholding of Promoter and Promoter Group
Nisarg Vakharia 178000.0 (1.78%) Public Shareholding
Nectar Biopharma Private Limited 60842.0 (0.61%) Shareholding of Promoter and Promoter Group
Smita Goyal 7.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

NURECA LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
24 Feb 2022 3.0 Interim 25 Feb 2022 Equity shares
21 Sep 2021 2.0 Final 23 Sep 2021 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
24 Feb 2022 3.0 Interim 25 Feb 2022 Equity shares
21 Sep 2021 2.0 Final 23 Sep 2021 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

NURECA LIMITED Share Price

The Company was formerly incorporated as Nureca Private Limited in India on 02 November 2016 under the provisions of Companies Act, 2013. The Company got converted from Private Limited Company to a Public Limited Company with effect from 08 July 2020 and the name of Company was changed to Nureca Limited. The Company is engaged in the business of home healthcare and wellness products.

The Company is a leading healthcare and wellness company with a product range of over 150 SKUs across different categories. The flagship brands such as Dr. Trust continue to enjoy high credibility and a loyal customer base. The products comply with USFDA, European CE, ROHS and ISO certifications, which reinforce customer's belief in their products. At present, the Company holds more than 100 design products.

Nureca is a digital first, B2C company. The Company sell products through implementation of various digital online platform channels like Flipkart, Amazon and website http://drtrust.in/. Dr. Trust is a pioneer in global healthcare and wellness brand with patented technologies and innovative solutions, helping users monitor chronic ailments. The Company is committed to creating products that support diagnosis, treatment and prevention of illness through monitoring and analysis of health data. Nureca's products are manufactured to be safe, accurate, long-lasting, and compliant with national and international regulations. The Company's growing range of connected devices is well entrenched in IoT and easy to sync with smart devices, while health app provides secure consolidation of data.

The Company is focused on leveraging its innovation, research, and data science capabilities to help and empower more people living with chronic and lifestyle diseases to live healthier and happier lives. The Company envisaged digital ecosystem and principles aims to provide integrated solutions aiding customers to maintain a suitable fitness regime, have clear understanding of and control over existing diseases
with easier health monitoring at home and optimum nutrition through quality nutraceuticals.

In 2017, the Company commenced business operations and launched 'Dr. Trust' brand through digital healthcare channel.

In 2018, the Company widened product basket with launching of brands in electric massages and mother & child care categories like Dr. Physio and Trumom. The Company started three flex centers in Punjab, Karnataka and Uttar Pradesh.

In 2019, the Company took the initiative for commencing business with WS retail. It increased the aggregate number of SKUs to 150. The Company added three flex centers in Tricity Chandigarh, Telangana and Maharashtra. The Company's key products secured a warehouse drug license.

In 2020, Company expanded presence through different channels and took initiative for starting business with 1mg, Pharmeasy, Paytm, and Croma retail stores.

The Company had taken the effect of demerger as per the Scheme of Arrangement among Nectar Biopharma Private Limited (demerged company) and Nureca Private Limited (resulting company) and their respective shareholders and creditors under Section 230 to 232 and other applicable provisions of the Companies Act 2013, which has been sanctioned by the Honorable National Company Law Tribunal (NCLT), Mumbai vide its Order dated 29 April 2020. The Scheme had become effective on 23 May 2020 (Effective date) on filing of certified copy of the Order with the Registrar of Companies. The Appointed Date from which the Scheme was operative was 1 April 2019. Pursuant to the Scheme of Demerger, certain portion of business activities of the demerged company was transferred by Nectar Biopharma Private Limited from the Appointed date of 1 April 2019.

In FY 2021, the Company received prestigious 'Economic Times Best Healthcare Brands Award 2021'.

Parent organization Indian Private
NSE symbol NURECA
Founded 2016
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Nureca Ltd?

Answer Field

The share price of Nureca Ltd for NSE is ₹ 231.01 and for BSE is ₹ 233.45.

What is the Market Cap of Nureca Ltd?

Answer Field

The market cap of Nureca Ltd for NSE is ₹ 2,31.01 Cr. and for BSE is ₹ 2,33.45 Cr. as of now.

What is the 52 Week High and Low of Nureca Ltd?

Answer Field

The 52 Week High and Low of Nureca Ltd for NSE is ₹ 447.50 and ₹ 203.62 and for BSE is ₹ 447.00 and ₹ 198.00.

How to Buy Nureca Ltd share?

Answer Field

You can trade in Nureca Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Nureca Ltd?

Answer Field

The 1 year returns on the stock has been -19.95%.

What is the Current Share Price of Nureca Ltd?

Answer Field

Nureca Ltd share price is for NSE ₹ 231.01 & for BSE ₹ 233.45 as on Apr 30 2025 03:14 PM.

What is the Market Cap of Nureca Ltd Share?

Answer Field

The market cap of Nureca Ltd for NSE ₹ 2,31.01 & for BSE ₹ 2,33.45 as on Apr 30 2025 03:14 PM.

What is the P/E Ratio of Nureca Ltd Share?

Answer Field

As on Apr 30 2025 03:14 PM the price-to-earnings (PE) ratio for Nureca Ltd share is -32.65.

What is the PB ratio of Nureca Ltd Share?

Answer Field

As on Apr 30 2025 03:14 PM, the price-to-book (PB) ratio for Nureca Ltd share is 193.42.

How to Buy Nureca Ltd Share?

Answer Field

You can trade in Nureca Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Nureca Ltd Share on Bajaj Broking App?

Answer Field

To buy Nureca Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Nureca Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|